F Dx Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$902.69 - $993.35 $622,856 - $685,411	-690 Reduced 70.26%	292 $281,000
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $186,043 - $211,608	240 Added 32.35%	982 $862,000
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $860,715 - $1.05 Million	-1,243 Reduced 62.62%	742 $610,000
Q2 2023 Jul 17, 2023	BUY	$700.03 - $830.35 $410,217 - $486,585	586 Added 41.89%	1,985 $1.43 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $534,358 - $580,157	-757 Reduced 35.11%	1,399 $1.01 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $357,583 - $451,251	-623 Reduced 22.42%	2,156 $1.49 Million
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $405,779 - $546,741	-740 Reduced 21.03%	2,779 $1.64 Million
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $7,141 - $8,381	-12 Reduced 0.34%	3,519 $2.46 Million
Q4 2021 Feb 01, 2022	BUY	$543.48 - $670.97 $982,068 - $1.21 Million	1,807 Added 104.81%	3,531 $2.23 Million
Q3 2021 Oct 08, 2021	SELL	$574.03 - $680.96 $12,628 - $14,981	-22 Reduced 1.26%	1,724 $1.04 Million
Q2 2021 Aug 05, 2021	SELL	$472.8 - $558.54 $211,341 - $249,667	-447 Reduced 20.38%	1,746 $975,000
Q1 2021 Apr 14, 2021	BUY	$446.73 - $548.2 $515,973 - $633,171	1,155 Added 111.27%	2,193 $1.04 Million
Q1 2021 Apr 13, 2021	SELL	$446.73 - $548.2 $19.7 Million - $24.2 Million	-44,193 Reduced 97.71%	1,038 $491,000
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $471,603 - $599,468	986 Added 2.23%	45,231 $21.9 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $1.78 Million - $2.15 Million	3,272 Added 7.99%	44,245 $24.8 Million
Q2 2020 Jul 22, 2020	BUY	$493.32 - $643.92 $214,594 - $280,105	435 Added 1.07%	40,973 $25.6 Million
Q1 2020 May 22, 2020	BUY	$336.18 - $494.43 $8.17 Million - $12 Million	24,298 Added 149.62%	40,538 $19.8 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $6.68 Million - $9.83 Million	-19,877 Reduced 55.04%	16,240 $444,000
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $4.74 Million - $6.51 Million	17,295 Added 91.89%	36,117 $13.6 Million
Q3 2019 Nov 07, 2019	BUY	$273.46 - $318.39 $1.26 Million - $1.47 Million	4,616 Added 32.49%	18,822 $5.22 Million
Q2 2019 Jul 19, 2019	BUY	$299.6 - $414.82 $3.09 Million - $4.28 Million	10,319 Added 265.47%	14,206 $4.45 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $19,348 - $22,857	52 Added 1.36%	3,887 $1.6 Million
Q4 2018 Apr 29, 2019	SELL	$335.82 - $403.04 $651,154 - $781,494	-1,939 Reduced 33.58%	3,835 $1.43 Million
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $436,230 - $523,548	1,299 Added 29.03%	5,774 $2.16 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $3,511 - $4,085	10 Added 0.22%	4,475 $1.81 Million
Q2 2018 Aug 08, 2018	BUY	$284.6 - $344.99 $115,263 - $139,720	405 Added 9.98%	4,465 $1.54 Million
Q1 2018 May 02, 2018	BUY	$315.82 - $393.78 $39,161 - $48,828	124 Added 3.15%	4,060 $1.4 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $24,386 - $31,956	68 Added 1.76%	3,936 $1.48 Million
Q3 2017 Nov 03, 2017	SELL	$431.38 - $504.0 $186,356 - $217,728	-432 Reduced 10.05%	3,868 $1.73 Million
Q2 2017 Aug 11, 2017	BUY	N/A	4,300	4,300 $2.11 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account